LOVELAND, Colo., Feb. 23,
2023 /PRNewswire/ -- Heska Corporation (NASDAQ:
HSKA - News; "Heska" or the "Company"), a leading global provider
of advanced veterinary diagnostic and specialty solutions,
announced that members of Heska's management team will present at
three institutional investor conferences in March 2023.
- Bank of America Securities 2023 Animal Health Summit,
March 2. Kevin Wilson, Chief Executive Officer and
President, will participate in a virtual fireside discussion at
1:20 p.m. ET.
- Raymond James Virtual 44th Annual Institutional
Investors Conference, March 7.
Mr. Wilson will present at 2:15 p.m.
ET and the presentation will be immediately followed by a
question and answer session.
- Barclays Global Healthcare Conference, March 14. Catherine Grassman, Executive
Vice President, Chief Financial Officer, will participate in a
fireside discussion at 3:05 p.m.
ET.
Company management will also participate in one-on-one meetings
at each event. Event webcasts and presentations can be accessed
through the links provided on the Heska Investor Relations website,
https://ir.heska.com/events/. For additional information, please
contact Heska Investor Relations at
investorrelations@heska.com.
About Heska
Heska Corporation (NASDAQ: HSKA) sells, manufactures, markets,
and supports diagnostic and specialty products and solutions for
veterinary practitioners. Heska's portfolio includes point-of-care
diagnostic laboratory instruments and consumables including rapid
assay diagnostic products and digital cytology services;
point-of-care digital imaging diagnostic products; local and
cloud-based data services; practice information management software
("PIMS") and related software and support; reference laboratory
testing; allergy testing and immunotherapy; heartworm preventive
products; and vaccines. Heska's primary focus is supporting
companion animal veterinarians in providing care to their patients.
Heska's business is composed of two operating and reportable
segments: North America and
International. North America
consists of the United States,
Canada and Mexico. International consists of geographies
outside of North America,
primarily in Germany, Italy, Spain,
France, Switzerland, Australia and Malaysia. The Company's strategic focus on
point-of-care diagnostic laboratory and imaging products is
included in both segments. The North
America segment also includes the contract manufacturing of
vaccines and pharmaceutical products and a small veterinary
laboratory, and the International segment includes PIMS business
and veterinary laboratories. For more information, please visit
www.heska.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/heska-to-present-at-three-upcoming-institutional-investor-conferences-301754105.html
SOURCE Heska Corporation